Related Experiment Video

Updated: Jun 10, 2026

Evaluation of Antimicrobial Activities of Nanoparticles and Nanostructured Surfaces In Vitro
11:52

Evaluation of Antimicrobial Activities of Nanoparticles and Nanostructured Surfaces In Vitro

Published on: April 21, 2023

Acute, multiple-dose dermal and genetic toxicity of Nu-3: a novel antimicrobial agent

Juan Sun1, Yanxin Hu, Shanping Cao

  • 1College of Veterinary Medicine, China Agricultura University, Beijing 100193, China.

Journal of Biomedicine & Biotechnology
|August 14, 2010
PubMed

Insights

Nu-3, a modified nucleotide, demonstrates low toxicity in toxicity studies. This antimicrobial compound shows promise for treating Pseudomonas aeruginosa infections due to its safety profile.

Area of Science:

  • Pharmacology
  • Toxicology
  • Microbiology

Background:

  • Nu-3 is a modified nucleotide with demonstrated antimicrobial activity against Pseudomonas aeruginosa.
  • Limited toxicological data exists for Nu-3, hindering its therapeutic development.

Purpose of the Study:

  • To comprehensively evaluate the toxicological profile of Nu-3.
  • To assess the safety of Nu-3 for potential therapeutic applications.

Main Methods:

  • Acute oral toxicity testing in mice (LD50 determination).
  • Dermal and mucous membrane irritation tests in rats.
  • Multiple-dose toxicity studies in rats.
  • In vitro and in vivo genotoxicity assays.

Main Results:

  • Nu-3 exhibited an LD50 of 2001 mg/kg in mice, indicating low acute oral toxicity.
  • Nu-3 was found to be non-irritant to dermal and mucous membranes in rats.
  • Multiple-dose administration of Nu-3 did not result in significant adverse histological, serum chemistry, or hematological changes.
  • No notable genotoxicity was observed in either in vitro or in vivo studies.

Conclusions:

  • Nu-3 possesses a favorable toxicological profile, characterized as hypotoxic or non-toxic.
  • The safety data supports further development of Nu-3 as a potential therapeutic agent for Pseudomonas aeruginosa infections.

More Related Videos

Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure08:25

Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure

Published on: June 5, 2020

Dissolving Microneedle Array Patches Manufactured By Solvent Casting Technique and Essential Characterization of Microneedle-Based Biomedical Devices08:26

Dissolving Microneedle Array Patches Manufactured By Solvent Casting Technique and Essential Characterization of Microneedle-Based Biomedical Devices

Published on: January 30, 2026

Related Concept Videos

Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Other Unique Bacteria01:18

Other Unique Bacteria

Magnetic bacteria exhibit a directed movement called magnetotaxis, driven by structures called magnetosomes. These magnetosomes consist of chains of magnetic particles made of either magnetite (Fe₃O₄) or greigite (Fe₃S₄) and are organized in a linear conformation by a protein scaffold within invaginations of the cell membrane. The bacteria align along the north–south magnetic field lines, much like a compass needle. They are typically microaerophilic or anaerobic and are commonly found near the...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...